Back to results
US 10,828,359 B2Granted
Anti-Mycobacterium tuberculosis vaccine using sendai virus as vector
AssigneesShanghai Public Health Clinical Center, Fudan University, ID Pharma Co., Ltd.
InventorsXiao-Yong Fan, Tsugumine Shu, Zhi-Dong Hu, Douglas B. Lowrie
Life of this patent
Estimating the term…
Abstract
Provided in the present application are a recombinant sendai virus vector vaccine expressing immunodominant antigens of Mycobacterium tuberculosis, and can be used as therapeutic and preventive antituberculosis vaccine.
Claims17
A Sendai virus vector vaccine, wherein said vector expresses a Mycobacterium tuberculosis immunogenic antigen comprising SEQ ID NO:
- 8 or a variant thereof that is at least 90% identical to SEQ ID NO:
- 8.
A recombinant Sendai virus vector, which is deposited at China Center for Type Culture Collection, under the accession number CCTCC V201518.
Dependencies are inferred from the claim text.